Starting insulin therapy in patients with type 2 diabetes: Effectiveness, complications, and resource utilization

JAMA

Volumn 278, Issue 20, 1997, Pages 1663-1669

  Hayward, Rodney A ^a,e   Manning, Willard G ^b   Kaplan, Sherrie H ^c   Wagner, Edward H ^d   Greenfield, Sheldon ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RESOURCE MANAGEMENT;

EID: 0030696063     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.20.1663     Document Type: Article

References (37)

1. West KM, Ahuja MM, Bennett PH, et al. The role of circulating glucose and triglyceride concentrations and their interaction with other risk factors as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diabetes Care. 1983;6:361-369.
2. Klein R, Klein BEK, Moss SE, et al. Glycosylated hemoglobin in a population-based study of diabetes. Am J Epidemiol. 1987;126:415-428.
3. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, III: prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmal. 1984;102:527-532.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
5. Peters AL, McCulloeh DK, Hayward RA, Deraco MR, Morrison AD. Case one: too little too latedelayed diagnosis of NIDDM. J Clin Outcomes Manag. 1994;1:9-26.
6. Colwell JA, Clark CM Jr. Forum two: unanswered research questions about metabolic control in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996;124(1, pt 2):178-179.
7. Colwell JA. Should we use intensive insulin therapy after oral agent failure in type II diabetes? Diabetes Care. 1996; 19:896-898.
8. U K Prospective Diabetes Study (UKPDS). VIII: study design, progress and performance. Diabetologia. 1991;34:877-890.
9. Abraira C, Colwell JA, Nuttall FQ, et al. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): results of the feasibility trial. Diabetes Care. 1995; 18:1113-1123.
10. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Rex Clin Pract. 1995;28:108-117.
11. Anderson RM, Hess GE, Davis WK, Hiss RG. Community diabetes care in the 1980s. Diabetes Care. 1988;11:519-526.
12. Greenfield S, Kaplan SH, Silliman RA, et al. The uses of outcomes research for medical effectiveness, quality of care, and reimbursement in type II diabetes. Diabetes Care. 1994;17:32-39.
13. McMahon LF, Greighton FA, Bernard AM, Pittinger WB. Kelley WN. The integrated inpatient management model: a new approach to clinical practice. Ann Intern Med. 1989;111:318-326.
14. Little RR, Wiedmeyer HM, England JD, Naito HK, Goldstein DE. Interlaboratory comparison of glycohemoglobin results: College of American Pathologists survey data. Clin Chem. 1991;37:1725-1729.
15. Greenfield S, Sullivan L, Silliman RA, Dukes K. Kaplan SH. Principles and practice of case mix adjustment: applications to end stage renal disease. Am J Kidney Dis. 1994;24:298-307.
16. Krousel-Wood MA, Abdoh A, Re R. Comparing comorbid-illness indices assessing outcome variation: the case of prostatectomy. J Gen Intern Med 1996;11:32-38.
17. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA. 1995;274:626-631.
18. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of coexistent disease in the occurrence of post operative complications and one year recovery in patients undergoing total hip replacement. Med Care. 1993;31:141-154.
19. Greenfield S, Sullivan L, Dukes KA, Silliman R, d'Agostino R, Kaplan SH. Development and testing of a new measures of case mix for use in office practice. Med Care. 1995;33(suppl):AS47-AS55.
20. Greenfield S, Sullivan L, Dukes KA, Silliman R, d'Agostino R, Kaplan SH. Estimating the impact of total illness burden on patient outcomes among patients with non-insulin dependent diabetes: comparison of three co-morbidity measures. J Gen Intern Med. 1995;10:67. Abstract.
21. McCullagh P, Nelder JA. Generalized Linear Models. 2nd ed. London, England: Chapman & Hall; 1989.
22. Pregibon D. Goodness of link tests for generalized linear models. Appl Stat. 1980;29:115-124.
23. Ramsey JB. Tests for specification errors in classical linear least squares regression analysis. J R Stat Soc B. 1969;31:350-371.
24. Tukey JW. One degree of freedom for non-additivity. Biometrics. 1949;5:232-242.
25. Manning WG, Duan N, Rogers WH. Monte Carlo evidence on the choice between sample selection and two-part models. J Econometrics. 1987;35: 59-82.
26. Manning WG, Morris CN. A two-part model of the demand for medical care: preliminary results from the health insurance experiment. In: van der Gaag J, Perlman M, eds. Health, Economics, and Health Economics. Amsterdam, the Netherlands: North Holland Publishing Co; 1981.
27. Duan N, Manning WG. A comparison of alternative models for the demand for medical care. J Econ Bus Stat. 1983;1:115-126.
28. The 1991, Red Book. Montvale, NJ: Medical Economics Co Inc; 1996.
29. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 1996;19(suppl 1):S8-S15.
30. Allen BT, DeLong ER, Feussner JR. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus: randomized controlled trial comparing blood and urine testing. Diabetes Care. 1990;13:1044-1050.
31. Klein CE, Oboler SK, Prochazka A, et al. Home blood glucose monitoring: effectiveness in a general population of patients who have non-insulin-dependent diabetes mellitus. J Gen Intern Med. 1993;8: 597-601.
32. Newman WP, Laqua D, Engelbrecht D. Impact of glucose self-monitoring on glycohemoglobin values in a veteran population. Arch Intern Med. 1990; 150:107-110.
33. Vijan S, Hayward RA, Hofer TP. Estimated benefits of glycemic control in type II diabetes: extrapolations from the DCCT. Ann Intern Med. 1997; 127:788-795.
34. Cave D. Capitated chronic disease management programs: a new market for pharmaceutical companies. Benefits Q. 1995;2:6-23.
35. Glauber H, Brown J. Use of health maintenance organization data bases to study pharmacy resource usage in diabetes mellitus. Diabetes Care. 1992;15: 870-876.
36. Wagner EH, Austin BT, VonKorff M. Organizing care for patients with chronic illness. Milbank Q. 1996;74:511-544.
37. Rettig B, Teutsch SM. The incidence of end-stage renal disease in type I and type II diabetes mellitus. Nebr Med J. 1985;70:370-373.